RNU7-47P

Across TCGA pan-cancer cohorts, RNU7-47P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU7-47P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU7-47P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU7-47P is over-expressed in tumor, although a few such as BRCA and COAD show the opposite, repressed pattern.

BRCA, COAD, and STAD are the cancer types where RNU7-47P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU7-47P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.630	<.001	6	view →
COAD	Female	II,III,IV	−0.365	.007	3	view →
STAD	Female	III,IV	+1.180	.024	1	view →
LUAD	Female	III,IV	−0.950	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RNU7-47P–BRCA

Open the BRCA breakdown →